Bubble CPAP therapy for neonatal respiratory distress in level III neonatal unit in Amman, Jordan: a prospective observational study

Manar Al-Lawama, Haitham Alkhatib, Zaid Wakileh, Randa Elqaisi, Ghada AlMassad, Eman Badran, Tyler Hartman, Manar Al-Lawama, Haitham Alkhatib, Zaid Wakileh, Randa Elqaisi, Ghada AlMassad, Eman Badran, Tyler Hartman

Abstract

Purpose: Bubble continuous positive airway pressure (bCPAP), a noninvasive respiratory support modality used to manage newborns with respiratory distress, provides continuous pressure that helps prevent derecruitment of alveoli, increasing the lungs' functional residual capacity, and thus decreasing the work of breathing. bCPAP can be used to manage various respiratory conditions in the newborn. In this prospective study, we describe our experience using bCPAP therapy as the primary respiratory support in a level III neonatal unit in Amman, Jordan. In addition to reporting therapeutic indications, durations, and side effects, we aimed to identify areas requiring improvement in bCPAP therapy in our population.

Patients and methods: This prospective observational study investigated the usage of bCPAP in the management of respiratory distress in newborns admitted to a Jordan University Hospital in Amman. The newborns were followed until discharge. The patients' demographic and clinical data were recorded.

Results: A total of 143 babies (mean gestational age, 36±2.7 weeks; mean birth weight, 2,770±1,800 g) were included. All received bCPAP as the primary respiratory support. The most common underlying cause of respiratory distress was transient tachypnea of the newborn (42%), followed by prolonged respiratory transition (34%). The therapy success rate was 93.7%; only nine infants failed bCPAP. The most common side effect was physical facial injury.

Conclusion: The use of neonatal bCPAP therapy is well established in Jordan University Hospital. The area of potential improvement was the low rate of bCPAP use as a primary respiratory support in extremely premature infants.

Keywords: developing countries; postnatal adaptation; respiratory distress syndrome; transient tachypnea of the newborn.

Conflict of interest statement

Disclosure The authors report no conflicts of interest in this work.

References

    1. Millar D, Kirpalani H. Benefits of non invasive ventilation. Indian Pediatr. 2004;41(10):1008–1011.
    1. Gregory GA, Kitterman JA, Phibbs RH, Tooley WH, Hamilton WK. Treatment of the idiopathic respiratory-distress syndrome with continuous positive airway pressure. N Engl J Med. 1971;284(24):1333–1340.
    1. Nowadzky T, Pantoja A, Britton JR. Bubble continuous positive airway pressure, a potentially better practice, reduces the use of mechanical ventilation among very low birth weight infants with respiratory distress syndrome. Pediatrics. 2009;123(6):1534–1540.
    1. Upadhyay A, Deorari AK. Continuous positive airway pressure – a gentler approach to ventilation. Indian Pediatr. 2004;41(5):459–469.
    1. Rezzonico R, Caccamo LM, Manfredini V, et al. Impact of the systematic introduction of low-cost bubble nasal CPAP in a NICU of a developing country: a prospective pre- and post-intervention study. BMC Pediatr. 2015;15:26.
    1. Dewez JE, van den Broek N. Continuous positive airway pressure (CPAP) to treat respiratory distress in newborns in low- and middle-income countries. Trop Doct. 2017;47(1):19–22.
    1. Jayashree M, KiranBabu HB, Singhi S, Nallasamy K. Use of nasal bubble CPAP in children with hypoxemic clinical pneumonia-report from a resource limited set-up. J Trop Pediatr. 2016;62(1):69–74.
    1. Abdulkadir I, Hassan L, Abdullahi F, Purdue S, Ogala WN. Nasal bubble CPAP: one year experience in a neonatal unit of a tertiary health facility in northwestern Nigeria. Niger Postgrad Med J. 2015;22(1):21–24.
    1. Cummings JJ, Polin RA, The Committee on Fetus and Newborn American Academy of Pediatrics Noninvasive respiratory support. Pediatrics. 2016;137(1):169–73.
    1. Bassiouny MR, Gupta A, El Bualy M. Nasal continuous positive airway pressure in the treatment of respiratory distress syndrome: an experience from a developing country. J Trop Pediatr. 1994;40(6):341–344.
    1. Gallacher DJ, Hart K, Kotecha S. Common respiratory conditions of the newborn. Breathe (Shef) 2016;12(1):30–42.
    1. Dehdashtian M, Aletayeb M, Malakian A, Aramesh MR, Malvandi H. Clinical course in infants diagnosed with transient tachypnea of newborn: a clinical trial assessing the role of conservative versus conventional management. J Chin Med Assoc. 2018;81(2):183–186.
    1. Sinha SK, Donn SM. Fetal-to-neonatal maladaptation. Semin Fetal Neonatal Med. 2006;11(3):166–173.
    1. Reuter S, Moser C, Baack M. Respiratory distress in the newborn. Pediatr Rev. 2014;35(10):417–428. quiz 429.
    1. Roberts CT, Davis PG, Owen LS. Neonatal non-invasive respiratory support: synchronised NIPPV, non-synchronised NIPPV or bi-level CPAP: what is the evidence in 2013? Neonatology. 2013;104(3):203–209.
    1. Kawaza K, Machen HE, Brown J, et al. Efficacy of a low-cost bubble CPAP system in treatment of respiratory distress in a neonatal ward in Malawi. PLoS One. 2014;9(1):e86327.
    1. Al-lawama M, Abdelghani T, Badran E. Mortality and short-term outcomes of very low birth weight infants at a tertiary care center in Jordan: comparison with other countries. Pediatr Ther. 2017;7:311.
    1. Askin DF. Fetal-to-neonatal transition – what is normal and what is not? Neonatal Netw. 2009;28(3):e33–e40.
    1. Hillman NH, Kallapur SG, Jobe AH. Physiology of transition from intrauterine to extrauterine life. Clin Perinatol. 2012;39(4):769–783.
    1. Gupta S, Donn SM. Continuous positive airway pressure: to bubble or not to bubble? Clin Perinatol. 2016;43(4):647–659.
    1. Liu J, Wang Y, Fu W, Yang CS, Huang JJ. Diagnosis of neonatal transient tachypnea and its differentiation from respiratory distress syndrome using lung ultrasound. Medicine (Baltimore) 2014;93(27):e197.
    1. Osman AM, El-Farrash RA, Mohammed EH. Early rescue neopuff for infants with transient tachypnea of newborn: a randomized controlled trial. J Matern Fetal Neonatal Med. 2017;16:1–7.
    1. Celebi MY, Alan S, Kahvecioglu D, et al. Impact of prophylactic continuous positive airway pressure on transient tachypnea of the newborn and neonatal intensive care admission in newborns delivered by elective cesarean section. Am J Perinatol. 2016;33(1):99–106.
    1. Yagui AC, Vale LA, Haddad LB, et al. Bubble CPAP versus CPAP with variable flow in newborns with respiratory distress: a randomized controlled trial. J Pediatr (Rio J) 2011;87(6):499–504.
    1. Rubarth LB, Quinn J. Respiratory development and respiratory distress syndrome. Neonatal Netw. 2015;34(4):231–238.
    1. Mahoney AD, Jain L. Respiratory disorders in moderately preterm, late preterm, and early term infants. Clin Perinatol. 2013;40(4):665–678.
    1. Jones M. Effect of preterm birth on airway function and lung growth. Paediatr Respir Rev. 2009;10(Suppl 1):9–11.
    1. Miller MJ, DiFiore JM, Strohl KP, Martin RJ. Effects of nasal CPAP on supraglottic and total pulmonary resistance in preterm infants. J Appl Physiol (1985) 1990;68(1):141–146.
    1. Bamat N, Jensen EA, Kirpalani H. Duration of continuous positive airway pressure in premature infants. Semin Fetal Neonatal Med. 2016;21(3):189–195.
    1. Hanin M, Nuthakki S, Malkar MB, Jadcherla SR. Safety and efficacy of oral feeding in infants with BPD on nasal CPAP. Dysphagia. 2015;30(2):121–127.
    1. Imbulana DI, Manley BJ, Dawson JA, Davis PG, Owen LS. Nasal injury in preterm infants receiving non-invasive respiratory support: a systematic review. Arch Dis Child Fetal Neonatal Ed. 2018;103(1):F29–F35.

Source: PubMed

Sponsoren und Mitarbeiter

Krankheiten

Drogeninterventionen

3
Abonnieren